Showing 308 results

Filters Content type: News, Editors' picks Topic: Drug interactions & pharmacokinetics

Taking two or more different drugs together may result in an alteration in the effectiveness or in the side-effects of one or more of the drugs. Pharmacokinetics (PK) is the study of how a drug is absorbed into the body and distributed in different parts of the body. Pharmacodynamics (PD) is the study of the impact of different concentrations of a drug on the body.

Drug interactions & pharmacokinetics

Small Study Finds No Need for Double-Dosing Dolutegravir After Switching From Failing Efavirenz-Based Regimen

Editor's pick
TheBodyPro
17 April 2024
Ageing & HIV

The US opioid crisis has reached older people with HIV

News
28 March 2024
PrEP policies & guidelines

Should event-driven PrEP be an option for women?

News
19 March 2024
The search for a cure

Varying dolutegravir distribution across the body may affect the drug’s ability to suppress the HIV reservoir

News
5 March 2024
Health problems & ageing

Polypharmacy Is Associated With More Falls and Slower Gait Speed in Older People With HIV, Study Reports

Editor's pick
TheBodyPro
12 February 2024
Ageing & HIV

Too many older people with HIV taking medicines they may not need

News
2 February 2024
Injectable & long-acting HIV treatment

Cabotegravir levels lower than trials in real-world study, but no increase in viral rebound

News
1 February 2024
PrEP science

Oral PrEP can work just as well for women as men, modelling studies conclude

News
29 December 2023
Antibody-based prevention

Oral tenofovir/FTC increases clearance of bNAb VRC01: implications for future research

Editor's pick
i-Base
4 December 2023
Changing treatment

Increasing and changing pattern of treatment switches among people with HIV

News
23 October 2023
Drug interactions & pharmacokinetics

Antiretroviral Dose Adjustment Is Rarely Needed for Obese People With HIV, Modeling Study Suggests

Editor's pick
TheBodyPro
18 September 2023
Pregnancy and vertical transmission

Bictegravir safe and effective in pregnancy

News
25 July 2023
TB treatment

Once-daily dolutegravir sufficient when taking TB treatment

News
16 June 2023
Drug interactions & pharmacokinetics

Can testing for drug-gene interactions improve treatment success in people with HIV?

News
15 June 2023
Injectable & long-acting PrEP

Good news for women and PrEP: quarterly dosing may work

News
23 February 2023
Contraception

New FSRH CEU guidance published: Drug Interactions Between HIV Antiretroviral Therapy (ART) and Contraception

Editor's pick
Faculty of Sexual and Reproductive Healthcare
7 February 2023
Drug interactions & pharmacokinetics

Protease-to-Integrase Switch Greatly Reduces HIV Drug-Drug Interaction Risk

Editor's pick
TheBodyPro
25 January 2023
Drug interactions & pharmacokinetics

Low levels of RPV-LA might explain failure with injectable ART despite perfect adherence

Editor's pick
i-Base
3 October 2022
Treatment guidelines

South Africa: Over 3 million people on new HIV drug, but not all smooth sailing

Editor's pick
Spotlight
1 June 2022
Drug interactions & pharmacokinetics

ViiV Healthcare has obtained marketing approval for the first and only complete long-acting treatment for HIV in Japan

Editor's pick
ViiV press release
31 May 2022
Cancer

Full-Dose Chemotherapy Regimen Appears Safe for Patients With HIV and Cancer

Editor's pick
Oncology Nurse Advisor
16 May 2022
Ageing & HIV

Polypharmacy Common Among Patients Aged 65 or Older With HIV

Editor's pick
Medscape (requires free registration)
28 April 2022
Drug interactions & pharmacokinetics

No Interactions Between Hormone Therapy and PrEP in Transgender Women or Men

Editor's pick
NATAP
24 February 2022
Ageing & HIV

Anticholinergic medications associated with falls and frailty in people ageing with HIV

News
15 February 2022